The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PROs) from TH3RESA, a phase 3 study of trastuzumab emtansine (T-DM1) versus treatment of physician’s choice (TPC) in patients with pretreated HER2-positive advanced breast cancer.
 
Karen Bartley
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Hans Wildiers
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Sung-Bae Kim
Research Funding - Novartis
 
Ian E. Krop
Research Funding - Genentech (Inst)
 
Jennifer Kang
Employment - Genentech
 
Ron Yu
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Abraham C. F. Leung
Employment - Roche/Genentech
 
Caroline Trudeau
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Antonio Gonzalez-Martin
No Relationships to Disclose